Gilead Sciences (GILD) Share-based Compensation Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
4.55% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
4.17% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
8.29% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5.13% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-11.76% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
4.31% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
60.00% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
1.39% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
4.31% |
| Dec 31, 2025 |
3.60% |
| Sep 30, 2025 |
6.48% |
| Jun 30, 2025 |
7.14% |
| Mar 31, 2025 |
11.76% |
| Dec 31, 2024 |
10.45% |
| Sep 30, 2024 |
6.93% |
| Jun 30, 2024 |
6.06% |
| Mar 31, 2024 |
13.33% |
| Dec 31, 2023 |
15.52% |
| Sep 30, 2023 |
20.24% |
| Jun 30, 2023 |
20.00% |
| Mar 31, 2023 |
26.92% |
| Dec 31, 2022 |
9.43% |
| Sep 30, 2022 |
-1.75% |
| Jun 30, 2022 |
-0.60% |
| Mar 31, 2022 |
-6.47% |
| Dec 31, 2021 |
-1.24% |
| Sep 30, 2021 |
-1.16% |
| Jun 30, 2021 |
15.28% |
| Mar 31, 2021 |
-1.42% |
| Dec 31, 2020 |
2.55% |
| Sep 30, 2020 |
6.79% |
| Jun 30, 2020 |
-17.24% |
| Mar 31, 2020 |
-1.40% |
| Dec 31, 2019 |
-10.29% |
| Sep 30, 2019 |
-18.18% |
| Jun 30, 2019 |
-30.95% |
| Mar 31, 2019 |
-35.00% |
| Dec 31, 2018 |
-47.60% |
| Sep 30, 2018 |
75.22% |
| Jun 30, 2018 |
147.06% |
| Mar 31, 2018 |
147.19% |
| Dec 31, 2017 |
227.45% |
| Sep 30, 2017 |
18.95% |
| Jun 30, 2017 |
7.37% |
| Mar 31, 2017 |
1.14% |
| Dec 31, 2016 |
5.15% |
| Sep 30, 2016 |
-2.06% |
| Jun 30, 2016 |
-1.04% |
| Mar 31, 2016 |
-4.35% |
| Dec 31, 2015 |
2.11% |
| Sep 30, 2015 |
-3.00% |
| Jun 30, 2015 |
15.66% |
| Mar 31, 2015 |
12.20% |
| Dec 31, 2014 |
32.48% |
| Sep 30, 2014 |
59.81% |
| Jun 30, 2014 |
48.34% |
| Mar 31, 2014 |
32.76% |
| Dec 31, 2013 |
24.92% |
| Sep 30, 2013 |
14.89% |
| Jun 30, 2013 |
15.60% |
| Mar 31, 2013 |
26.75% |
| Dec 31, 2012 |
23.17% |
| Sep 30, 2012 |
17.94% |
| Jun 30, 2012 |
-3.44% |
| Mar 31, 2012 |
-1.49% |
| Dec 31, 2011 |
-12.65% |
| Sep 30, 2011 |
-10.85% |
| Jun 30, 2011 |
4.32% |
| Mar 31, 2011 |
5.61% |
| Dec 31, 2010 |
27.56% |
| Sep 30, 2010 |
18.99% |
| Jun 30, 2010 |
20.23% |
| Mar 31, 2010 |
14.12% |
